The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
Exceeding the target of 1.50 lakh Ayushman Bharat - Health & Wellness Centres (AB-HWC) by 31 December, 2022, more than 1.54 lakh Sub Health Centres and Primary Health Centres have been transformed as AB-HWCs
Acquisitions have the potential to add at least $1 billion in sales by 2028
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
More women centric initiatives being the need of the hour for holistic development
Subscribe To Our Newsletter & Stay Updated
